NUTX Stock Overview
Nutex Health Inc. operates as a network of micro-hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Nutex Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.46 |
| 52 Week High | US$52.80 |
| 52 Week Low | US$0.50 |
| Beta | 0 |
| 1 Month Change | -16.09% |
| 3 Month Change | 25.86% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.35% |
Recent News & Updates
Shareholder Returns
| NUTX | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 13.2% | -3.5% | -1.8% |
| 1Y | n/a | -33.2% | -10.9% |
Return vs Industry: Insufficient data to determine how NUTX performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how NUTX performed against the US Market.
Price Volatility
| NUTX volatility | |
|---|---|
| NUTX Average Weekly Movement | 21.6% |
| Healthcare Services Industry Average Movement | 10.1% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NUTX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 22% a week.
Volatility Over Time: NUTX's weekly volatility has decreased from 29% to 22% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 1,500 | Tom Vo | https://www.nutexhealth.com |
Nutex Health Inc. operates as a network of micro-hospitals. It operates through two segments: Healthcare and Real Estate. The Healthcare segment is comprised of corporate-level entities, ERs, and PLLCs.
Nutex Health Inc. Fundamentals Summary
| NUTX fundamental statistics | |
|---|---|
| Market Cap | US$950.64m |
| Earnings (TTM) | US$158.87m |
| Revenue (TTM) | US$374.26m |
6.0x
P/E Ratio2.5x
P/S RatioIs NUTX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUTX income statement (TTM) | |
|---|---|
| Revenue | US$374.26m |
| Cost of Revenue | US$0 |
| Gross Profit | US$374.26m |
| Other Expenses | US$215.39m |
| Earnings | US$158.87m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 100.00% |
| Net Profit Margin | 42.45% |
| Debt/Equity Ratio | 43.0% |
How did NUTX perform over the long term?
See historical performance and comparison